Point-of-care evaluation of a rapid antigen test (CLINITEST ® Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals

Several studies evaluating the performance of Rapid antigen assays (RAD) for the diagnosis of SARS-VCoV-2 infection have been recently published in this Journal.1-3 Decentralized testing for SARS-CoV-2 infection is one of the cornerstones of controlling the COVID-19 pandemic.4 RAD based on lateral flow immunochromatography (LFIC) technology offer advantages over molecular assays for the purpose, as they are low-cost, easy-to-use and instrument-free devices. An increasing number of RAD LFIC assays are being marketed nowadays.
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: LETTER TO THE EDITOR Source Type: research